Advisor Group Holdings, Inc. Cyclacel Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.28 - $0.75 $1,106 - $2,962	-3,950 Reduced 30.15%	9,150 $3,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $1,120 - $2,300	2,000 Added 18.02%	13,100 $7,000
Q3 2022 Nov 14, 2022	BUY	$1.23 - $21.9 $13,653 - $243,089	11,100 New	11,100 $16,000
Q1 2022 May 04, 2022	SELL	$5.93 - $7.6 $11,860 - $15,200	-2,000 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$7.59 - $10.48 $15,180 - $20,960	2,000 New	2,000 $12,000

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $7.9M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.